Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Relentless Prescription Drug Price Increases

Relentless Prescription Drug Price Increases Opinion EDITORIAL Chaarushena Deb; Gregory Curfman, MD One in 4 people in the US has difficulty paying the cost of that include provisions requiring drug price transparency to their prescription medications. This stark fact was recently aid consumers in purchasing prescription drugs. However, reported in a 2019 Kaiser Family Foundation public opinion these state actions generally do not help patients because poll among a nationally representative random sample of they do not require the disclosure of real transaction prices at 1205 adults. Persons who each stage of the drug distribution process. The Trump reported having the greatest administration has also proposed a price transparency rule, Related articles pages 834, difficulty affording their pre- whereby pharmaceutical companies would be required to 844, and 854 scription drugs were those include their wholesale acquisition (list) prices in drug adver- who most needed them, including those who took 4 or more tisements. This proposal, however, is unlikely to survive a prescription drugs, spent $100 or more per month on their legal challenge by the industry. drugs, and reported being in fair or poor health. In another state-level proposal, Governor Gavin Newsom In response to relentless increases in prescription drug of California recently signed http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Relentless Prescription Drug Price Increases

JAMA , Volume 323 (9) – Mar 3, 2020

Loading next page...
 
/lp/american-medical-association/relentless-prescription-drug-price-increases-kgv0Ig788Q
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2020.0359
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL Chaarushena Deb; Gregory Curfman, MD One in 4 people in the US has difficulty paying the cost of that include provisions requiring drug price transparency to their prescription medications. This stark fact was recently aid consumers in purchasing prescription drugs. However, reported in a 2019 Kaiser Family Foundation public opinion these state actions generally do not help patients because poll among a nationally representative random sample of they do not require the disclosure of real transaction prices at 1205 adults. Persons who each stage of the drug distribution process. The Trump reported having the greatest administration has also proposed a price transparency rule, Related articles pages 834, difficulty affording their pre- whereby pharmaceutical companies would be required to 844, and 854 scription drugs were those include their wholesale acquisition (list) prices in drug adver- who most needed them, including those who took 4 or more tisements. This proposal, however, is unlikely to survive a prescription drugs, spent $100 or more per month on their legal challenge by the industry. drugs, and reported being in fair or poor health. In another state-level proposal, Governor Gavin Newsom In response to relentless increases in prescription drug of California recently signed

Journal

JAMAAmerican Medical Association

Published: Mar 3, 2020

References